The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy. Headlines
– Twitter threatens trade secrets lawsuit over Meta’s Threads app https://on.ft.com/44xxGtp – US regulators approve first drug to slow progression of Alzheimer’s https://on.ft.com/46xnuDj
– FIS sells majority stake in Worldpay to buyout group at $18.5 bln valuation https://on.ft.com/44xmw83 – RMT announce fresh strikes on London Underground in late July https://on.ft.com/44pBxsC
Overview – Elon Musk-owned Twitter on Thursday threatened to sue Meta Platforms over its new Threads platform, which attracted more than 30 million sign ups after it was launched on Wednesday.
– The U.S. Food and Drug Administration said on Thursday it granted full approval for the first Alzheimer’s drug Leqembi, which is developed by Eisai and Biogen. – Private equity firm GTCR has agreed to buy a majority stake in Worldpay, the merchant payments unit of Fidelity National Information Services, in a deal that values the unit at $18.5 billion.
– UK’s trade union RMT said on Thursday that London underground rail staff will go on a five-day strike from July 23-28 over pensions and working conditions. (Compiled by Bengaluru newsroom)
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
